PPA
DICE

Parametric Portfolio Associates’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Parametric Portfolio Associates’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$855K Buy
44,710
+17,238
+63% +$308K ﹤0.01% 2847
2021
Q4 		$695K Buy
+27,472
New +$805K ﹤0.01% 2936

Other funds holding DICE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Parametric Portfolio Associates's DICE Position: Q1 2022 in Review

Parametric Portfolio Associates increased its DICE Therapeutics, Inc. Common Stock (DICE) stake by 63% in Q1 2022, buying an estimated $308K and bringing the position to 44,710 shares worth $855K. The position accounts for ﹤0.01% of the portfolio, ranked #2847.

Parametric Portfolio Associates first reported a position in DICE in Q4 2021 and has held it in 2 quarters since. 76 funds tracked by Wall St. Rank hold DICE as of Q1 2022.

  • Parametric Portfolio Associates held 44,710 shares of DICE Therapeutics, Inc. Common Stock worth $855K as of Q1 2022.
  • Parametric Portfolio Associates bought 17,238 DICE Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $308K.
  • DICE Therapeutics, Inc. Common Stock made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2847 holding.
  • Parametric Portfolio Associates first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2021 and has held it in 2 quarters since.
  • 76 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.